EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 1st, 2021 • Eloxx Pharmaceuticals, Inc. • Services-commercial physical & biological research • Massachusetts
This EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) between Eloxx Pharmaceuticals, Inc. (the “Company”), and Vijay Modur (the “Executive”) is dated as of April 1, 2021 and shall become effective on the date hereof (the “Effective Date”).
AGREEMENT AND PLAN OF MERGER BY AND AMONG ELOXX PHARMACEUTICALS, INC. AND Delta Merger Sub Acquisition Corporation AND ZIKANI THERAPEUTICS, INC. DATED AS OF APRIL 1, 2021Agreement and Plan of Merger • April 1st, 2021 • Eloxx Pharmaceuticals, Inc. • Services-commercial physical & biological research • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), is made as of April 1, 2021, by and among Eloxx Pharmaceuticals, Inc., a Delaware corporation (“Parent”), Delta Merger Sub Acquisition Corporation, a Delaware corporation and direct, wholly owned subsidiary of Parent (“Merger Sub”), and Zikani Therapeutics, Inc., a Delaware corporation (the “Company”).
SEPARATION AGREEMENT AND GENERAL RELEASESeparation Agreement and General Release • April 1st, 2021 • Eloxx Pharmaceuticals, Inc. • Services-commercial physical & biological research • Massachusetts
This Separation Agreement and General Release (this “Agreement”), dated as of the date set forth on the signature page hereto, is entered into by and between Eloxx Pharmaceuticals, Inc. (the “Company”) and Gregory C. Williams (“Williams”).
